Clinical Features Of Women With COPD: Sex Differences In A Cross-Sectional Study In Spain (“The ESPIRAL-ES Study”)

References

• Viegi G, Pistelli F, Sherrill DL, Maio S, Baldacci S, Carrozzi L. Definition, epidemiology and natural history of COPD. Eur Respir J. 2007;30(5):993–1013. doi:10.1183/09031936.0008250717978157
   PubMed Web of Science ®Google Scholar
• Guarascio AJ, Ray SM, Finch CK, Self TH. The clinical and economic burden of chronic obstructive pulmonary disease in the USA. Clincoecon Outcomes Res. 2013;5:235–245. doi:10.2147/CEOR.S34321
   PubMedGoogle Scholar
• Miravitlles M, Ribera A. Understanding the impact of symptoms on the burden of COPD. Respir Res. 2017;18:67. doi:10.1186/s12931-017-0548-328431503
   PubMed Web of Science ®Google Scholar
• GBD. 2015 Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5(9):691–707.28822787
   PubMed Web of Science ®Google Scholar
• Tsiligianni I, Román Rodríguez M, Lisspers K, LeeTan T, Infantino A. Call to action: improving care for women with COPD. Prim Care Respir Med. 2017;27:11. doi:10.1038/s41533-017-0013-2
   PubMed Web of Science ®Google Scholar
• Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med. 2000;160(11):1683–1689.10847262
   PubMed Web of Science ®Google Scholar
• Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance–United States, 1971–2000. MMWR Surveill Summ. 2002;51(6):1–16.
   Google Scholar
• Laviolette L, Lacasse Y, Doucet M, et al. Chronic obstructive pulmonary disease in women. Can Respir J. 2007;14(2):93–98.17372636
   PubMed Web of Science ®Google Scholar
• Ställberg B, Janson C, Johansson G, et al. Management, morbidity and mortality of COPD during an 11-year period: an observational retrospective epidemiological register study in Sweden (PATHOS). Prim Care Respir J. 2014;23(1):38–45.24346825
   PubMedGoogle Scholar
• Ntritsos G, Franek J, Belbasis L, et al. Sex-specific estimates of COPD prevalence: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2018;13:1507–1514. doi:10.2147/COPD.S14639029785100
   PubMed Web of Science ®Google Scholar
• Ancochea J, Miravitlles M, García-Río F, et al. Underdiagnosis of chronic obstructive pulmonary disease in women: quantification of the problem, determinants and proposed actions. Arch Bronconeumol. 2013;49(6):223–229. doi:10.1016/j.arbres.2012.11.01023317767
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Soriano JB, García-Río F, et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax. 2009;64(10):863–868. doi:10.1136/thx.2009.11572519553233
   PubMed Web of Science ®Google Scholar
• DeMeo DL, Ramagopalan S, Kavati A, et al. Women manifest more severe COPD symptoms across the life course. Int J Chron Obstruct Pulmon Dis. 2018;13:3021–3029. doi:10.2147/COPD.S16027030319250
   PubMed Web of Science ®Google Scholar
• Hardin M, Foreman M, Dransfield MT, et al. Sex-specific features of emphysema among current and former smokers with COPD. Eur Respir J. 2016;47(1):104–112. doi:10.1183/13993003.00996-201526541532
   PubMed Web of Science ®Google Scholar
• Sansores RH, Ramírez-Venegas A. COPD in women: susceptibility or vulnerability? Eur Respir J. 2016;47(1):19–22. doi:10.1183/13993003.01781-201526721958
   PubMed Web of Science ®Google Scholar
• Alcázar-Navarrete B, Trigueros JA, Riesco JA, Campuzano A, Pérez J. Geographic variations of the prevalence and distribution of COPD phenotypes in Spain: “the ESPIRAL-ES study”. Int J Chron Obstruct Pulmon Dis. 2018;13:1115–1124. doi:10.2147/COPD.S15803129692606
   PubMed Web of Science ®Google Scholar
• Global strategy for the diagnosis, management and prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2014. Available from: http://www.goldcopd.org Accessed 915, 2016.
   Google Scholar
• Miravitlles M, Soler-Cataluña JJ, Calle M, et al. Spanish COPD guidelines (GesEPOC): pharmacological treatment of stable COPD. Spanish Society of Pulmonology and Thoracic Surgery. Arch Bronconeumol. 2012;48(7):247–257. doi:10.1016/j.arbres.2012.04.00122561012
   PubMed Web of Science ®Google Scholar
• Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest. 1988;93(3):580–586. doi:10.1378/chest.93.3.5803342669
   PubMed Web of Science ®Google Scholar
• Soler-Cataluña JJ, Martínez-García MA, Sánchez Sánchez L, Perpiñá Tordera M, Román Sánchez P. Severe exacerbations and BODE index: two independent Risk factors for death in male COPD patients. Respir Med. 2009;103(5):692–699. doi:10.1016/j.rmed.2008.12.00519131231
   PubMed Web of Science ®Google Scholar
• Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34(3):648–654. doi:10.1183/09031936.0010250919720809
   PubMed Web of Science ®Google Scholar
• Soler-Cataluña JJ, Cosío B, Izquierdo JL, et al. Consensus document on the overlap phenotype COPD-asthma in COPD. Arch Bronconeumol. 2012;48(9):331–337. doi:10.1016/j.arbres.2011.12.00922341911
   PubMed Web of Science ®Google Scholar
• British Lung Foundation. Chronic obstructive pulmonary disease statistics. Available from: https://statistics.blf.org.uk/copd Accessed 124, 2019.
   Google Scholar
• Ford ES, Croft JB, Mannino DM, Wheaton AG, Zhang X, Giles WH. COPD surveillance–United States, 1999–2011. Chest. 2013;144(1):284–305. doi:10.1378/chest.13-080923619732
   PubMed Web of Science ®Google Scholar
• Chronic obstructive pulmonary disease. Data and statistics. Available from: https://www.cdc.gov/copd/data.html Accessed 124, 2019.
   Google Scholar
• Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD study): a population-based prevalence study. Lancet. 2007;370(9589):741–750. doi:10.1016/S0140-6736(07)61377-417765523
   PubMed Web of Science ®Google Scholar
• Hill K, Goldstein RS, Guyatt GH, et al. Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care. CMAJ. 2010;182(7):673–678. doi:10.1503/cmaj.09178420371646
   PubMed Web of Science ®Google Scholar
• Chapman KR, Tashkin DP, Pye DJ. Sex bias in the diagnosis of COPD. Chest. 2001;119(6):1691–1695. doi:10.1378/chest.119.6.169111399692
   PubMed Web of Science ®Google Scholar
• Wheaton AG, Pleasants RA, Croft JB, et al. Sex and asthma-chronic obstructive pulmonary disease overlap syndrome. J Asthma. 2016;53(7):720–731. doi:10.3109/02770903.2016.115407227043854
   PubMed Web of Science ®Google Scholar
• Koblizek V, Milenkovic B, Barczyk A, et al. Phenotypes of COPD patients with a smoking history in Central and Eastern Europe: the POPE Study. Eur Respir J. 2017;49(5):1601446. doi:10.1183/13993003.01446-201628495687
   PubMed Web of Science ®Google Scholar
• Mindus S, Malinovschi A, Ekerljung L, et al. Asthma and COPD overlap (ACO) is related to a high burden of sleep disturbance and respiratory symptoms: results from the RHINE and Swedish GA2LEN surveys. PLoS One. 2018;13(4):e0195055. doi:10.1371/journal.pone.019505529608582
   PubMed Web of Science ®Google Scholar
• Golpe R, Sanjuán López P, Cano Jiménez E, Castro Añón O, Pérez de Llano LA. Distribution of clinical phenotypes in patients with chronic obstructive pulmonary disease caused by biomass and tobacco smoke. Arch Bronconeumol. 2014;50(8):318–324. doi:10.1016/j.arbres.2013.12.01324576449
   PubMed Web of Science ®Google Scholar
• Lamprecht B, McBurnie MA, Vollmer WM, et al. COPD in never smokers: results from the population-based burden of obstructive lung disease study. Chest. 2011;139(4):752–763. doi:10.1378/chest.10-125320884729
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Ferrer M, Pont A, et al. Characteristics of a population of COPD patients identified from a population-based study. Focus on previous diagnosis and never smokers. Respir Med. 2005;99(8):985–995. doi:10.1016/j.rmed.2005.01.01215950139
   PubMed Web of Science ®Google Scholar
• Iribarren C, Friedman GD, Klatsky AL, Eisner MD. Exposure to environmental tobacco smoke: association with personal characteristics and self reported health conditions. J Epidemiol Community Health. 2001;55(10):721–728. doi:10.1136/jech.55.10.72111553655
   PubMed Web of Science ®Google Scholar
• Larsson ML, Loit HM, Meren M, et al. Passive smoking and respiratory symptoms in the FinEsS study. Eur Respir J. 2003;21(4):672–676. doi:10.1183/09031936.03.0003370212762355
   PubMed Web of Science ®Google Scholar
• Cavaillès A, Brinchault-Rabin G, Dixmier A, et al. Comorbidities of COPD. Eur Respir Rev. 2013;22(130):454–475. doi:10.1183/09059180.0000861224293462
   PubMedGoogle Scholar
• Graat-Verboom L, Wouters EF, Smeenk FW, van Den Borne BE, Lunde R, Spruit MA. Current status of research on osteoporosis in COPD: a systematic review. Eur Respir J. 2009;34(1):209–218.19567604
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Soler-Cataluña JJ, Calle M, et al. Spanish guidelines for management of chronic obstructive pulmonary disease (GesEPOC) 2017. Pharmacological treatment of stable phase. Arch Bronconeumol. 2017;53(6):324–335.28477954
   PubMed Web of Science ®Google Scholar
• Global Initiative for chronic obstructive lung disease. Pocket guide to COPD diagnosis, management, and prevention. A guide for health care professionals. 2018 Report. Available from: https://goldcopd.org/wp-content/uploads/2018/02/WMS-GOLD-2018-Feb-Final-to-print-v2.pdf Accessed 14, 2019.
   Google Scholar
• Varkey AB. Chronic obstructive pulmonary disease in women: exploring sex differences. Curr Opin Pulm Med. 2004;10(2):98–103.15021178
   PubMed Web of Science ®Google Scholar
• Cote CG, Chapman KR. Diagnosis and treatment considerations for women with COPD. Int J Clin Pract. 2009;63(3):486–493.19222634
   PubMed Web of Science ®Google Scholar
• Rodríguez-González Moro JM, Izquierdo JL, Antón E, de Lucas P, Martín A. Health-related quality of life in outpatient women with COPD in daily practice: the MUVICE Spanish study. Respir Med. 2009;103(9):1303–1312.19406631
   PubMed Web of Science ®Google Scholar
• Jenkins CR, Chapman KR, Donohue JF, Roche N, Tsiligianni I, Han MK. Improving the management of COPD in women. Chest. 2017;151(3):686–696.27816445
   PubMed Web of Science ®Google Scholar